Deva was founded in 1958 with the aim of collecting small savings to form a capital of a large company and to direct these savings towards industrialization of Turkey. The target of Deva project was to be a leader and a model in fast accumulation of capital, to direct this potential to industrial development of Turkey with investments requiring high capital, finally to provide a higher standard of living by passing over the profits to the public. Founded with this main principle, Deva initially invested in the pharmaceutical industry.
Various activities on the pharmaceutical industry and on other fields were a result of new dimensions gained by the company. This led to the decision of the General Assembly on
March 14 th 1970 to change the status of the company into a Holding and its name to
Deva Holding A.S.
  		• 1958 Established by 27 founding shareholders
  		• 1960 First manufacturing facility established
  		• 1970 Foundation of first API production facility in Turkey
  		• 1978 Acquisition of Carlo Erba
  		• 1991 Foundation of Cerkezköy synthesis plant
  		• 1994 Launch of Potassium Clavulanate production
  		• 1997 Launch of Cefuroxime Axetil production
  		• 2000 Paid in capital was raised to 16 trillion TL
  		• 2003 Paid in capital was raised to 48 trillion TL
  		• 2004 Amoklavin ranked as best selling drug in Turkey